Back to SGEN Stock Lookup

Seattle Genetics (SGEN) – StreetInsider.com Reports

Jan 5, 2017 12:46 PM Seattle Genetics (SGEN) Says ClinicalTrials.gov has Wrong Classification for Adcetris/Opdivo Trial Suspension, Working to Fix Within 24 Hours - Bloomberg
Jan 5, 2017 12:21 PM Seattle Genetics (SGEN): Adcetris + Opdivo trial 'going well' - Bloomberg
Jan 5, 2017 11:29 AM UPDATE: Seattle Genetics (SGEN) Sees Mid-Day Pressure as Trial Enrollment Suspended
Jan 4, 2017 11:14 AM New Gilead (GILD) Hire Makes Incyte (INCY) a Likely Takeover Target - Gabelli
Jan 4, 2017 06:40 AM Goldman Expects Oncology M&A To Be Active In 2017, Sees (GILD), (JNJ), (PFE), (MRK), (NVS), (SNY), (LLY) As Possible Acquirers
Dec 27, 2016 03:09 PM Merus N.V. (MRUS) Gains on Seattle Genetics' (SGEN) AML Setback
Dec 27, 2016 01:54 PM Unusual 11 Mid-Day Movers 12/27: (MBRX) (CYCC) (RADA) Higher; (ELGX) (SGEN) (GSAT) Lower (more...)
Dec 27, 2016 12:48 PM Seattle Genetics (SGEN) PT Lowered to $60 at Credit Suisse Given Increased Risk to AML Programs Following Clinical Hold
Dec 27, 2016 10:45 AM Needham & Company Tells Seattle Genetics (SGEN) Investors Not to Overreact About Vadastuximab Clinical Hold
Dec 27, 2016 09:22 AM Pre-Open Stock Movers 12/27: (CAPN) (IONS) (BIIB) Higher; (ELGX) (SGEN) (AVXS) Lower (more...)
Dec 27, 2016 08:30 AM Seattle Genetics (SGEN) Falls 14% as Trading Resumes Following Clinical Hold
Dec 27, 2016 08:12 AM Seattle Genetics (SGEN) Set to Resume Trading at 8:30AM ET Following SGN-CD33A Clinical Hold
Dec 27, 2016 08:00 AM Seattle Genetics (SGEN) FDA Places Clinical Hold on Several Phase 1 Trials of Vadastuximab Talirine
Dec 27, 2016 07:55 AM Seattle Genetics (SGEN) halted, news pending
Dec 20, 2016 04:36 PM Piper Jaffray's Top Potential Surprises in Biopharma for 2017
Dec 12, 2016 07:15 AM Credit Suisse Downgrades Seattle Genetics (SGEN) to Neutral
Dec 6, 2016 06:18 AM Seattle Genetics (SGEN), Bristol-Myers (BMY) Present First Data from ADCETRIS + Opdivo Phase 1/2 in r/r HL
Dec 5, 2016 01:05 PM Seattle Genetics (SGEN) Offers LT Follow-up Data on ADCETRIS in T-Cell Lymphomas; Median CR Duration Not Reached
Dec 5, 2016 06:36 AM Seattle Genetics (SGEN), Takeda Pharma Announce Positive Data from ADCETRIS Phase 3 in CD30-Expressing Cutaneous T-Cell Lymphoma
Nov 29, 2016 08:18 AM UPDATE: Barclays Downgrades Seattle Genetics (SGEN) to Equalweight
Nov 10, 2016 08:07 AM Seattle Genetics (SGEN) Granted FDA Breakthrough Therapy Designation for ADCETRIS
Nov 8, 2016 08:04 AM Seattle Genetics (SGEN), Takeda Announce Completion of ADCETRIS Phase 3 Enrollment in rontline Mature T-cell Lymphoma
Oct 27, 2016 06:11 PM After-Hours Stock Movers 10/27: (CVRS) (SMCI) (GIMO) (LOGM) (CRUS) (HBI) (VRSN) (CBI) (SGEN) (ACTG) (CY) Higher; (SYMX) (YRCW) (SYNA) (CENX) (MXK) (ATEN) (MLNX) (ASNG) (AMZN) Lower
Oct 27, 2016 04:13 PM Seattle Genetics (SGEN) Tops Q3 EPS by 6c
Oct 26, 2016 02:46 PM Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report
Oct 21, 2016 09:05 AM Leerink Partners Remains Bullish Ahead of Seattle Genetics's (SGEN) 3Q Report
Oct 20, 2016 08:07 AM Seattle Genetics (SGEN) Updates on Multiple Presentations Made at ISHL
Oct 13, 2016 09:20 AM Pre-Open Stock Movers 10/13: (OCUL) (ESRP) (ULTA) Higher; (FLDM) (TGTX) (MELI) Lower (more...)
Oct 12, 2016 05:20 PM Seattle Genetics (SGEN) Files 44.1M Share Common Stock Shelf for Selling Shareholders
Oct 7, 2016 02:09 PM Leerink Says Seattle Genetics' (SGEN) Pipeline Value Drivers Still Underappreciated
Oct 7, 2016 09:02 AM Seattle Genetics (SGEN), Agensys Present Updated ASG-22ME, ASG-15ME Data at ESMO 2016
Oct 4, 2016 08:05 AM Seattle Genetics (SGEN) Names New CTO, SVP
Sep 15, 2016 06:52 AM Goldman Sachs Upgrades Seattle Genetics (SGEN) to Neutral
Aug 1, 2016 12:12 PM Streetinsider.com's Hot Lunchtime Reads 8/1: (AXTA) (SCTY) (XON) (SGEN)
Aug 1, 2016 10:58 AM Seattle Genetics (SGEN) PT Raised to $52 at Leerink Partners
Aug 1, 2016 06:59 AM Seattle Genetics (SGEN), Takeda Announce Statistically Significant Phase 3 ALCANZA Data
Jul 27, 2016 07:22 AM Cantor Fitzgerald Downgrades Seattle Genetics (SGEN) to Hold
Jul 26, 2016 04:52 PM Seattle Genetics (SGEN) Tops Q2 EPS by 9c
Jul 25, 2016 02:40 PM Trading Radar for 7/26: Apple (AAPL), McDonald's (MCD), 3M (MMM), Caterpillar (CAT), Verizon (VZ), [Conference Call] Under Armour (UA) Report
Jul 18, 2016 10:05 AM Seattle Genetics (SGEN), Takeda Announces Publication of Final ADCETRIS Phase 2 Data in r/r Hodgkin Lymphoma
Jul 6, 2016 08:11 AM Takeda Announces Receipt of EC Approval for ADCETRIS as Post-Transplant Hodgkin Lymphoma Treatment (SGEN)
Jun 29, 2016 07:56 AM Credit Suisse Sees $157B of FCF Through 2019 Available for M&A in Biotech/Pharma Sector
Jun 28, 2016 07:52 AM Seattle Genetics (SGEN): Adcetris Could Become a Blockbuster - Needham
Jun 24, 2016 11:13 AM Needham & Company Weighs in on Brexit Biotech Impact (ACAD) (GILD0 (ICPT) (SGEN)
Jun 6, 2016 08:05 AM Seattle Genetics (SGEN), Astellas Pharma Will Present ASG-15ME, ASG-22ME Data at ASCO
Apr 28, 2016 04:34 PM Seattle Genetics (SGEN) Misses Q1 EPS by 6c
Apr 27, 2016 12:45 PM Trading Radar for 4/28: Ford (F), Amazon (AMZN), Viacom (VIAB), LinkedIn (LNKD), Pandora (P), Aetna (AET) Report
Apr 18, 2016 08:02 AM Seattle Genetics (SGEN) Highlights Data SupportING ADC Immuno-Oncology programs at AACR
Mar 2, 2016 04:44 PM SunTrust Starts Seattle Genetics (SGEN) at Neutral
Feb 22, 2016 08:12 AM Seattle Genetics (SGEN) Initiates Phase 1/2 Trial of Vadastuximab Talirine Combination for Patients with Untreated MDS

Back to SGEN Stock Lookup